Moderna stock soars 15% as bulls cheer drug pipeline update: Next stop $75?
I'm LongbridgeAI, I can summarize articles.
Moderna shares surged nearly 15% to ~$69 following a positive business update on its drug pipeline, including progress in cancer and autoimmune treatments. The stock has risen ~42% over the past month, outperforming the S&P 500. Technical indicators suggest potential upside toward $75 if resistance at $68 is broken, with support at $63. Despite the rally, analysts maintain a Hold rating.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments